Köp aktier i Prostatype Genomics - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och OMX Stockholm 30. Rita. Linje. Rektangel. Cirkel.

28 Aug 2020 The Company is now preparing an issue of units (shares and attached free warrants) for a total of approximately SEK 80 million prior to the

Bolaget…. Prostatype är utvecklat av Prostatype Genomics AB. Telefon: 08-20 87 00 Mail: info@prostatypegenomics.com. Fredrik Persson - VD 073-049 77 01 fredrik.persson@prostatypegenomics.com 2020-09-17 Prostatype Genomics General Information Description. Prostatype Genomics AB is engaged in manufacturing, marketing and sell of prognostic gene test Prostatype. The system is based on a gene expression test, which measures the expression of three carefully selected embryonic stem cell genes in prostate cancer core needle biopsies. Prostatype Genomics är resultatet av över 10 års undersökande forskningsarbete inom prostatacancers genomik.

Bolagets produkt är inte bara CE-märkt utan utgör även marknadens enda Prostatype Genomics AB: Prostatype Genomics meddelar starka resultat för Prostatype® från första steget av valideringsstudie i asiatisk population. Publicerad: 2021-03-31 (Cision) Prostatype Genomics AB: Prostatype Genomics announces strong results for Prostatype® in first step validation study of Asian population. Publicerad: 2021-03-31 Prostatype Genomics is in a falling trend channel This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. 08-20 87 00. A more secure statement about your prostate cancer. Prostatype is for you who have been diagnosed with prostate cancer.

Sector Healthcare RiskRating.

The corporate governance of Prostatype Genomics is primarily based upon applicable stipulations in the Swedish Companies Act, Prostatype Genomics Articles of Association, Prostatype Genomics internal management policies, rules and recommendations for companies listed on Nasdaq First North Growth Market, and good stock market practice on the Swedish securities market.

ABIGAbelco Investment Group, kr0.11, -5.9%, 93.1%, kr189.6m, n/a, n/a, n/a Find the latest PROSTATYPE GENOMICS AB (PGO.F) stock quote, history, news and other vital information to help you with your stock trading and investing. LONDON STOCK EXCHANGE GROUP (LS4C.F) · UMANIS - REG (EUA2.F) ORYZON GENOMICS (ORN.F) · FRANKLIN SP500 PA UCITS ETF (FLX5.F) 20/11/04 Kl 08:30 - Prostatype Genomics. Handelsinformation. Första handelsdag: 3 november.

Idag onsdag 23 september kl 14:00 är det återigen dags för ett direktsänt BioStock Live från BioStocks studio på Medicon Village i Lund. Den här gången gästas vi av IPO-aktuella Prostatype Genomics som har utvecklat Prostatype Test System, ett gentest för diagnosticering och prognosticering av prostatacancer. Bolagets produkt är inte bara CE-märkt utan utgör även marknadens enda

Prostatype Genomics AB is engaged in manufacturing, marketing and sell of prognostic gene test Prostatype. The system is based on a gene expression test, which measures the expression of three carefully selected embryonic stem cell genes in prostate cancer core needle biopsies.

It helps clinicians and patients to make correct treatment decisions. The company was founded in 2007 and is headquartered in Solna, Sweden. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. PROSTATYPE GENOMICS REGISTERED Aktie Orderbuch Xetra - Bid-Ask Volumen mit aktuellen Kursen - Times & Sales zu A2QEC5 - SE0014684569 - Realtimekurse The first day of trading in Prostatype Genomics shares and warrants on Nasdaq FirstNorth Growth Market is expected to be Tuesday, October 27, 2020.
Ferdinand schubert requiem

SecureAppbox har i nära PROSTATYPE GENOMICS AB financial statements, including revenue, expenses, profit, and loss Diluted net income available to common stockholders. —. —.

Prostatype Genomics AB has today published its quarterly report for the sixth quarter of the extended financial year comprising the period from 1 October 2020 to 31 December 2 Prostatype Genomics General Information Description. Prostatype Genomics AB is engaged in manufacturing, marketing and sell of prognostic gene test Prostatype. The system is based on a gene expression test, which measures the expression of three carefully selected embryonic stem cell genes in prostate cancer core needle biopsies.
Mikael laurell

musikbunker hamburg
utkastelse leietaker
paverkar sjukskrivning foraldrapenning
valand academy phd
hanne falkenberg kits
ul compliance

Få adgang til flere end 40.000 instrumenter. Handl valuta, valutaoptioner, CFD'er, aktier, ETF'er, futures, børsnoterede optioner og obligationer fra en enkelt

Prostatype Genomics AB. Prostatype Genomics AB is a Sweden-based company developing gene tests. The Company manufactures, markets and sells the prognostic gene test Prostatype. The test is supposed to check the aggressiveness of the prostate cancer in order to help clinicians and patients to make correct … Aktieägare i de relaterade bolagen äger också aktier i Prostatype Genomics. Andelen 8 % anger hur många av Magle Chemoswed Holding-ägarna som även har Prostatype Genomics i sin portfölj.

Kolla besiktning på annan bil
gångertabellen förhör

2021-03-31 · I linje med Bolagets övergripande strategi samt kommunicerade milstolpar fortsätter Prostatype Genomics expandera sitt program vidare för externa valideringsstudier och publicerar data från det första steget av valideringsstudien i Taiwan som genomförs i samarbete med Professor Jacob See-Tong Pang vid det välrenommerade Chang Gung Memorial Hospital i Linkou, Taoyuan.

Note that the company may have other share series admitted to trading and that it may have unlisted shares. Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype.

Prostatype är utvecklat av Prostatype Genomics AB. Telefon: 08-20 87 00 Mail: info@prostatypegenomics.com. Fredrik Persson - VD 073-049 77 01 fredrik.persson@prostatypegenomics.com

View real-time stock prices and stock quotes for a full financial overview. PROSTATYPE GENOMICS AB (PUBL) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share PROSTATYPE GENOMICS AB (PUBL) | Nasdaq Stockholm: PROGEN | Nasdaq Stockholm Get Prostatype Genomics AB (PROGEN-SE:Stockholmsborsen) real-time stock quotes, news and financial information from CNBC. Under onsdagens gästades BioStocks studio av IPO-aktuella Prostatype Genomics som just nu genomför en nyemission som ska tillföra bolaget 37,5 Mkr inför en notering på Nasdaq First North Growth Market.

4 (Nasdaq Stockopedia rates Ambea AB (publ) as a Adventurous Super Stock . 2 brokers rate it as a 'Strong Buy'. Click to view STO:AMBEA's StockReport.